Andover, MA, United States of America

Sally T Ishizaka

This inventor holds 19 USPTO granted patents and 5 published patent applications, plus 4 CIPO patents and 6 EPO patents. Top assignees: Eisai R&d Management Co., Ltd., Eisai Company, Limited, Eisai R&d Co., Ltd.. Active years: 2001-2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Sally T Ishizaka. Retrieved from https://idiyas.com/inventor/sally-t-ishizaka

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 19 

% Patents Active = 84.2

 

 

Average Co-Inventor Count = 5.1

ph-index = 7

Forward Citations = 178(Granted Patents)


Location History:

  • Andover, MA (US) (2011)
  • Weston, MA (US) (2001 - 2021)

Company Filing History:


Years Active: 2001-2021

Loading Chart...
Loading Chart...
Loading Chart...
19 patents (USPTO):Explore Patents

Title: The Innovative Journey of Sally T Ishizaka

Introduction: Sally T Ishizaka is a pioneering inventor based in Andover, MA, known for her groundbreaking contributions to various fields.

Latest Patents: Sally T Ishizaka holds several patents in the areas of technology, healthcare, and sustainability, showcasing her diverse range of expertise.

Career Highlights: With a career spanning over two decades, Sally T Ishizaka has worked with top research institutions and companies, leading the way in developing cutting-edge solutions to complex problems.

Collaborations: Throughout her career, Sally T Ishizaka has collaborated with renowned inventors, patent attorneys, and industry experts, fostering a culture of innovation and excellence.

Conclusion: Sally T Ishizaka's passion for innovation and her relentless pursuit of excellence continue to inspire the next generation of inventors and entrepreneurs.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…